UPDATE 1-Pfizer?s Ibrance drug slows progression of breast cancer
 

UPDATE 1-Pfizer?s Ibrance drug slows progression of breast cancer
CHICAGO May 30 (Reuters) - A Phase III trial of Pfizer Inc's Ibrance showed that, in combination with hormonetherapy, the drug more than doubled the duration of diseasecontrol for women with the...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Po:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...Po:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/shmPeSKZgbE